Complete Filing Data
Phio Pharmaceuticals Corp. reported Net Income Loss of -$8.70 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Phio Pharmaceuticals Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | $399.0K | $97.0K | |||||||||||||||
| Net Income Loss | -$8.7M | -$7.2M | -$10.8M | -$11.5M | -$13.3M | -$8.8M | -$8.9M | -$7.4M | -$12.5M | -$9.0M | -$10.2M | -$8.8M | -$20.9M | -$12.9M | -$2.5M | -$12.0M | -$18.4M | -$14.4M | -$11.0M | -$2.4M | -$2.2M | -$3.3M | -$89.0K |
| Research And Development Expense | $4.6M | $3.6M | $6.3M | $7.0M | $8.9M | $3.7M | $4.3M | $4.3M | $5.4M | $5.4M | $6.9M | $5.7M | $17.7M | $10.5M | $6.6M | ||||||||
| General And Administrative Expense | $4.6M | $3.7M | $4.4M | $4.5M | $4.6M | $5.1M | $4.7M | $3.2M | $4.0M | $3.6M | $3.3M | $3.2M | $3.7M | $2.6M | $6.1M | ||||||||
| Operating Income Loss | -$9.2M | -$7.4M | -$10.8M | -$11.5M | -$13.5M | -$8.8M | -$9.0M | -$7.4M | -$14.1M | -$9.0M | -$10.2M | -$8.8M | -$20.9M | -$13.0M | -$12.8M | ||||||||
| Operating Expenses | $9.2M | $7.4M | $10.8M | $11.5M | $13.5M | $8.8M | $9.0M | $7.5M | $14.1M | $9.0M | $10.3M | $8.9M | $21.3M | $13.1M | |||||||||
| Nonoperating Income Expense | -$2.0K | -$18.0K | $224.0K | -$1.0K | $79.0K | $4.0K | -$11.0K | $21.0K | $14.0K | $26.0K | |||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$12.5M | -$11.1M | -$10.4M | -$12.9M | -$29.5M | -$25.7M | -$10.2M | ||||||||||||||||
| Other Nonoperating Income Expense | $2.0K | $6.0K | -$10.0K | $6.0K | -$2.0K | $9.0K | $125.0K | $2.6M | |||||||||||||||
| Interest Income Expense Nonoperating Net | -$9.0K | -$1.0K | -$1.0K | $15.0K | $16.0K | $17.0K | $24.0K | ||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.5M | -$13.3M | -$8.8M | -$8.9M | -$7.4M | -$14.1M | -$9.0M | -$10.2M | -$8.8M | -$20.9M | -$12.9M | -$10.2M | |||||||||||
| Revenue From Grants | $34.0K | $71.0K | $399.0K | $97.0K | |||||||||||||||||||
| Deferred Revenue Current | $47.0K | $118.0K | $491.0K | $816.0K | |||||||||||||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $0.00 | $4.7M | $228.0K | $12.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $21.0K | $57.0K | $58.0K | $23.0K | $0.00 | $0.00 | $9.0K | $10.0K | $34.0K | $29.0K | $92.0K | $225.0K | $53.0K | $57.0K | |||||||||||||||||||||||||
| Net Income Loss | -$2.4M | -$2.2M | -$1.8M | -$1.5M | -$1.8M | -$2.2M | -$2.8M | -$2.5M | -$3.6M | -$3.6M | -$2.5M | -$2.6M | -$3.7M | -$2.7M | -$3.4M | -$2.3M | -$1.7M | -$2.4M | -$2.1M | -$2.0M | -$2.1M | -$1.5M | -$1.9M | -$2.2M | -$2.5M | -$2.5M | -$5.5M | -$2.2M | -$2.2M | -$2.2M | -$2.5M | -$2.2M | -$2.9M | -$2.2M | -$2.0M | -$2.3M | -$2.1M | -$2.0M | -$14.4M | -$1.6M | -$7.6M | -$1.9M | -$2.0M | -$1.9M |
| Research And Development Expense | $1.2M | $1.1M | $886.0K | $644.0K | $866.0K | $1.1M | $1.8M | $1.4M | $2.1M | $2.5M | $1.3M | $1.6M | $2.7M | $1.6M | $2.4M | $1.3M | $779.0K | $1.2M | $1.0M | $1.1M | $1.1M | $838.0K | $1.2M | $1.4M | $1.5M | $1.3M | $1.3M | $1.5M | $1.3M | $1.3M | $1.7M | $1.4M | $2.1M | $1.5M | $1.2M | $1.5M | $1.2M | $1.2M | $13.8M | $1.2M | $6.9M | $1.2M | $1.1M | $1.8M |
| General And Administrative Expense | $1.3M | $1.2M | $986.0K | $946.0K | $1.0M | $1.1M | $968.0K | $1.2M | $1.5M | $1.1M | $1.2M | $1.1M | $1.1M | $1.1M | $1.2M | $1.1M | $890.0K | $1.1M | $1.1M | $913.0K | $1.1M | $711.0K | $774.0K | $901.0K | $986.0K | $1.1M | $1.1M | $752.0K | $885.0K | $950.0K | $770.0K | $804.0K | $873.0K | $766.0K | $850.0K | $843.0K | $934.0K | $977.0K | $676.0K | $539.0K | $716.0K | $751.0K | $1.0M | $1.0M |
| Operating Income Loss | -$2.5M | -$2.3M | -$1.9M | -$1.6M | -$1.9M | -$2.2M | -$2.8M | -$2.5M | -$3.6M | -$3.6M | -$2.5M | -$2.6M | -$3.7M | -$2.7M | -$3.6M | -$2.3M | -$1.7M | -$2.4M | -$2.1M | -$2.1M | -$2.1M | -$1.5M | -$1.9M | -$2.2M | -$2.5M | -$2.5M | -$7.1M | -$2.2M | -$2.2M | -$2.2M | -$2.5M | -$2.2M | -$2.9M | -$2.2M | -$2.0M | -$2.3M | -$2.1M | -$2.0M | -$14.4M | -$1.7M | -$7.7M | -$1.9M | -$2.2M | |
| Operating Expenses | $2.5M | $2.3M | $1.9M | $1.6M | $1.9M | $2.2M | $2.8M | $2.5M | $3.6M | $3.6M | $2.5M | $2.6M | $3.7M | $2.7M | $3.6M | $2.3M | $1.7M | $2.4M | $2.1M | $2.1M | $2.2M | $1.5M | $2.0M | $2.3M | $2.5M | $2.5M | $7.1M | $2.2M | $2.2M | $2.3M | $2.5M | $2.2M | $3.0M | $2.2M | $2.0M | $2.3M | $2.2M | $2.2M | $14.4M | $1.8M | $7.7M | $1.9M | $2.8M | |
| Nonoperating Income Expense | $143.0K | -$22.0K | $66.0K | $68.0K | $2.0K | -$4.0K | -$2.0K | $0.00 | -$5.0K | -$10.0K | -$2.0K | -$3.0K | -$3.0K | $231.0K | -$3.0K | -$3.0K | $5.0K | $19.0K | $24.0K | $27.0K | -$1.0K | -$2.0K | $0.00 | $0.00 | $0.00 | $0.00 | $4.0K | $3.0K | $14.0K | $8.0K | -$1.0K | $1.0K | $3.0K | $15.0K | ||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$2.2M | -$2.2M | -$2.2M | -$2.5M | -$2.2M | -$3.1M | -$2.9M | -$3.2M | -$4.0M | -$3.5M | -$4.4M | -$17.9M | -$2.9M | -$18.2M | -$1.9M | -$2.0M | -$1.9M | |||||||||||||||||||||||||||
| Other Nonoperating Income Expense | $0.00 | $0.00 | -$1.0K | $7.0K | -$2.0K | -$1.0K | $10.0K | $2.0K | -$3.0K | $53.0K | $70.0K | $1.0K | $123.0K | $955.0K | ||||||||||||||||||||||||||||||
| Interest Income Expense Nonoperating Net | -$3.0K | -$3.0K | -$2.0K | -$3.0K | -$3.0K | $5.0K | $4.0K | $4.0K | $7.0K | $8.0K | $1.0K | $1.0K | $4.0K | $5.0K | $6.0K | $10.0K | $4.0K | |||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.5M | -$1.9M | -$2.2M | -$2.5M | -$2.5M | -$7.1M | ||||||||||||||||||||||||||||||||||||||
| Revenue From Grants | $34.0K | $16.0K | $12.0K | $29.0K | $92.0K | $225.0K | $53.0K | $57.0K | ||||||||||||||||||||||||||||||||||||
| Deferred Revenue Current | $61.0K | $78.0K | $89.0K | $147.0K | $239.0K | $464.0K | $370.0K | $468.0K | $797.0K | |||||||||||||||||||||||||||||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $0.00 | $0.00 | $0.00 | $85.0K | $4.6M | $228.0K | $12.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $20.1M | $4.7M | $7.7M | $10.8M | $21.9M | $13.0M | $5.7M | $13.6M | $1.8M | $10.9M | $8.9M | $2.7M | $4.9M | -$5.8M | -$587.0K | $2.4M | $741.0K | $9.0M | $10.8M | $2.0K |
| Cash And Cash Equivalents At Carrying Value | $21.0M | $5.4M | $8.5M | $12.9M | $5.1M | $8.5M | $11.4M | $5.1M | $503.0K | |||||||||||
| Property Plant And Equipment Net | $11.0K | $2.0K | $6.0K | $183.0K | $133.0K | $157.0K | $210.0K | $172.0K | $248.0K | $114.0K | $163.0K | $183.0K | $177.0K | $198.0K | $355.0K | |||||
| Liabilities And Stockholders Equity | $21.5M | $5.7M | $9.4M | $12.8M | $25.2M | $15.7M | $8.0M | $15.3M | $4.1M | $13.4M | $11.2M | $9.2M | $14.9M | $5.6M | $1.7M | |||||
| Assets Current | $21.5M | $5.7M | $9.3M | $12.4M | $24.7M | $15.2M | $7.3M | $15.2M | $3.8M | $13.1M | $11.0M | $9.0M | $14.7M | $5.4M | $1.3M | |||||
| Assets | $21.5M | $5.7M | $9.4M | $12.8M | $25.2M | $15.7M | $8.0M | $15.3M | $4.1M | $13.4M | $11.2M | $9.2M | $14.9M | $5.6M | $1.7M | |||||
| Accrued Liabilities Current | $905.0K | $762.0K | $942.0K | $1.0M | $2.7M | $1.4M | $964.0K | $1.2M | $1.8M | $1.6M | $1.1M | $1.0M | $1.8M | $767.0K | $544.0K | |||||
| Accounts Payable Current | $435.0K | $253.0K | $657.0K | $779.0K | $283.0K | $728.0K | $809.0K | $550.0K | $511.0K | $917.0K | $1.2M | $285.0K | $163.0K | $416.0K | $387.0K | |||||
| Liabilities Current | $1.6M | $1.9M | $3.1M | $2.2M | $1.9M | $1.7M | $2.3M | $2.5M | $2.3M | $1.3M | $2.1M | $1.7M | $1.8M | |||||||
| Common Stock Value | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $1.0K | $2.0K | $1.0K | $10.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.8M | $24.1M | $14.3M | $7.0M | $14.9M | $3.6M | $13.0M | $5.2M | ||||||||||||
| Retained Earnings Accumulated Deficit | -$155.1M | -$146.4M | -$139.2M | -$128.4M | -$116.9M | -$103.6M | -$94.8M | -$85.9M | -$78.6M | -$66.1M | -$57.1M | -$46.9M | -$38.1M | |||||||
| Prepaid Expense And Other Assets Current | $445.0K | $354.0K | $832.0K | $615.0K | $620.0K | $870.0K | $316.0K | $221.0K | $201.0K | $150.0K | $303.0K | $212.0K | $186.0K | |||||||
| Other Assets Noncurrent | $0.00 | $3.0K | $24.0K | $27.0K | $18.0K | $18.0K | $0.00 | $18.0K | $27.0K | $18.0K | $18.0K | $18.0K | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Liabilities | $1.3M | $1.0M | $1.6M | $2.0M | $3.2M | $2.7M | $2.3M | $1.7M | $2.1M | $1.7M | $2.3M | |||||||||
| Cash And Cash Equivalents Period Increase Decrease | $7.8M | -$3.4M | -$2.9M | $6.3M | $4.6M | |||||||||||||||
| Restricted Cash | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | |||||||||||||
| Cash Contributions From Parent Company | $1.5M | $11.6M | $7.7M | $7.9M | $15.7M | |||||||||||||||
| Restricted Cash And Cash Equivalents | $50.0K | $50.0K | $50.0K | $50.0K | $53.0K | $53.0K | ||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $0.00 | $33.0K | $128.0K | $122.0K | $117.0K | $111.0K | $109.0K | |||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $33.0K | $161.0K | $283.0K | $400.0K | $511.0K | $0.00 | |||||||||||||
| Operating Lease Liability Current | $0.00 | $35.0K | $135.0K | $125.0K | $116.0K | $107.0K | $0.00 | |||||||||||||
| Non Cash Equity Adjustments From Parent Company | -$8.1M | -$2.3M | -$1.8M | $750.0K | $4.3M | |||||||||||||||
| Cash | $21.0M | $5.4M | $8.5M | $12.9M | $5.1M | $8.5M | $11.4M | $5.1M | $503.0K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$3.1M | -$3.3M | -$12.3M | $9.8M | $7.3M | -$7.9M | $11.3M | |||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $35.0K | $170.0K | $295.0K | $411.0K | $0.00 | ||||||||||||||
| Preferred Stock Dividends And Other Adjustments | $8.6M | $12.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q1 2006 | Q4 2005 | Q4 2004 | Q4 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.8M | $10.1M | $12.2M | $4.9M | $3.8M | $5.6M | $7.2M | $9.9M | $7.3M | $13.5M | $17.0M | $19.5M | $25.2M | $28.8M | $31.4M | $15.5M | $17.7M | $12.0M | $7.6M | $9.7M | $11.7M | $1.8M | $3.3M | $567.0K | $3.4M | $5.9M | $8.2M | $3.0M | $5.0M | $7.0M | $11.0M | $13.1M | $2.5M | $4.7M | $6.6M | $6.2M | $7.0M | $6.7M | $8.1M | -$4.3M | -$2.8M | -$1.8M | $0.00 | -$450.0K | -$968.0K | -$89.0K | ||||||
| Cash And Cash Equivalents At Carrying Value | $10.7M | $10.8M | $13.3M | $5.4M | $4.7M | $6.5M | $8.4M | $11.3M | $3.2M | $5.3M | $2.6M | $3.6M | $5.4M | $7.7M | $10.2M | $2.4M | $3.8M | $4.2M | $4.0M | $6.0M | $6.6M | $5.1M | $11.9M | $9.0M | $6.8M | $8.6M | $19.6M | $6.3M | $7.5M | $304.0K | ||||||||||||||||||||||
| Property Plant And Equipment Net | $12.0K | $7.0K | $4.0K | $1.0K | $1.0K | $2.0K | $142.0K | $157.0K | $167.0K | $198.0K | $206.0K | $215.0K | $153.0K | $142.0K | $145.0K | $173.0K | $183.0K | $202.0K | $231.0K | $152.0K | $155.0K | $187.0K | $207.0K | $228.0K | $269.0K | $275.0K | $105.0K | $124.0K | $135.0K | $149.0K | $162.0K | $181.0K | $170.0K | $193.0K | $204.0K | $155.0K | $130.0K | $147.0K | $172.0K | $235.0K | $282.0K | $315.0K | ||||||||||
| Liabilities And Stockholders Equity | $11.5M | $11.3M | $13.4M | $5.9M | $5.3M | $6.9M | $9.5M | $12.3M | $9.7M | $15.8M | $20.1M | $22.2M | $27.9M | $31.7M | $33.9M | $18.2M | $20.2M | $14.3M | $10.1M | $12.1M | $13.7M | $3.8M | $6.0M | $3.1M | $6.0M | $8.4M | $10.5M | $4.9M | $6.5M | $8.2M | $12.7M | $15.0M | $7.2M | $10.9M | $12.6M | $12.5M | $16.2M | $18.0M | $20.0M | $6.7M | $8.0M | $1.3M | ||||||||||
| Assets Current | $11.5M | $11.3M | $13.4M | $5.9M | $5.3M | $6.8M | $9.3M | $12.0M | $9.4M | $15.4M | $19.7M | $21.7M | $27.5M | $31.2M | $33.3M | $17.6M | $19.6M | $13.6M | $9.3M | $11.4M | $12.9M | $3.6M | $5.8M | $2.9M | $5.7M | $8.1M | $10.4M | $4.8M | $6.4M | $8.0M | $12.5M | $14.8M | $7.0M | $10.7M | $12.3M | $12.3M | $16.1M | $17.8M | $19.8M | $6.5M | $7.7M | $1.0M | ||||||||||
| Assets | $11.5M | $11.3M | $13.4M | $5.9M | $5.3M | $6.9M | $9.5M | $12.3M | $9.7M | $15.8M | $20.1M | $22.2M | $27.9M | $31.7M | $33.9M | $18.2M | $20.2M | $14.3M | $10.1M | $12.1M | $13.7M | $3.8M | $6.0M | $3.1M | $6.0M | $8.4M | $10.5M | $4.9M | $6.5M | $8.2M | $12.7M | $15.0M | $7.2M | $10.9M | $12.6M | $12.5M | $16.2M | $18.0M | $20.0M | $6.7M | $8.0M | $1.3M | ||||||||||
| Accrued Liabilities Current | $1.2M | $971.0K | $843.0K | $735.0K | $1.2M | $929.0K | $2.1M | $1.6M | $1.4M | $1.5M | $1.8M | $2.1M | $2.1M | $2.1M | $1.5M | $1.4M | $1.3M | $1.1M | $1.1M | $1.1M | $703.0K | $1.6M | $2.2M | $2.0M | $1.9M | $1.7M | $1.6M | $1.4M | $1.3M | $940.0K | $1.4M | $1.2M | $1.1M | $958.0K | $682.0K | $1.0M | $1.0M | $913.0K | $1.1M | $877.0K | $610.0K | $537.0K | ||||||||||
| Accounts Payable Current | $516.0K | $235.0K | $427.0K | $184.0K | $335.0K | $320.0K | $173.0K | $641.0K | $902.0K | $543.0K | $1.1M | $329.0K | $322.0K | $348.0K | $615.0K | $742.0K | $481.0K | $685.0K | $856.0K | $736.0K | $721.0K | $491.0K | $542.0K | $521.0K | $702.0K | $741.0K | $672.0K | $457.0K | $297.0K | $281.0K | $222.0K | $635.0K | $459.0K | $137.0K | $293.0K | $277.0K | $177.0K | $358.0K | $366.0K | $155.0K | $277.0K | $747.0K | ||||||||||
| Liabilities Current | $1.2M | $1.3M | $1.0M | $919.0K | $1.5M | $1.2M | $2.3M | $2.4M | $2.4M | $2.2M | $3.0M | $2.6M | $2.5M | $2.6M | $2.2M | $2.2M | $1.9M | $1.9M | $2.0M | $1.9M | $1.5M | $2.1M | $2.8M | $2.5M | $2.6M | $2.5M | $2.3M | $1.9M | $1.6M | $1.2M | $1.7M | $1.8M | $1.6M | $1.2M | $1.1M | $1.4M | $1.3M | $1.5M | $2.0M | $1.4M | $1.4M | $2.1M | ||||||||||
| Common Stock Value | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $3.0K | $3.0K | $2.0K | $0.00 | $0.00 | $0.00 | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $6.0K | $6.0K | $3.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $32.0K | $16.0K | $16.0K | $16.0K | $10.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.8M | $13.3M | $5.4M | $5.4M | $4.7M | $6.5M | $8.5M | $8.5M | $11.4M | $9.1M | $14.5M | $18.1M | $20.5M | $26.6M | $29.5M | $32.7M | $16.9M | $18.9M | $13.3M | $8.8M | $10.9M | $12.8M | $3.3M | $5.4M | $2.7M | $5.5M | $7.8M | $10.3M | ||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$152.7M | -$150.3M | -$148.1M | -$144.7M | -$143.2M | -$141.4M | -$137.3M | -$134.5M | -$132.0M | -$125.6M | -$122.1M | -$119.5M | -$113.4M | -$109.7M | -$107.0M | -$101.2M | -$98.8M | -$97.2M | -$92.2M | -$90.1M | -$88.0M | -$84.2M | -$82.7M | -$80.8M | -$76.5M | -$74.1M | -$71.6M | -$63.8M | -$61.5M | -$59.3M | -$54.5M | -$52.0M | -$49.8M | -$44.6M | -$42.4M | |||||||||||||||||
| Prepaid Expense And Other Assets Current | $788.0K | $519.0K | $158.0K | $474.0K | $594.0K | $373.0K | $871.0K | $678.0K | $319.0K | $871.0K | $1.7M | $577.0K | $702.0K | $640.0K | $267.0K | $533.0K | $507.0K | $117.0K | $332.0K | $459.0K | $206.0K | $432.0K | $718.0K | $351.0K | $442.0K | $510.0K | $367.0K | $226.0K | $181.0K | $209.0K | $102.0K | $144.0K | $162.0K | $58.0K | ||||||||||||||||||
| Other Assets Noncurrent | $0.00 | $3.0K | $3.0K | $3.0K | $6.0K | $6.0K | $24.0K | $27.0K | $27.0K | $27.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $0.00 | $0.00 | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | |||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.6M | $9.4M | |||||||||||||||||||||||
| Liabilities | $1.7M | $1.2M | $1.3M | $2.3M | $2.4M | $2.4M | $2.3M | $3.1M | $2.7M | $2.7M | $2.8M | $2.5M | $2.8M | $2.5M | $2.3M | $2.5M | $2.4M | $2.0M | $1.3M | $1.5M | $2.0M | $1.4M | $1.4M | $3.1M | ||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$925.0K | -$1.9M | -$2.4M | $14.5M | -$199.0K | |||||||||||||||||||||||||||||||||||||||||||||||
| Restricted Cash | $0.00 | $0.00 | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | ||||||||||||||||||||||||||||||||
| Cash Contributions From Parent Company | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restricted Cash And Cash Equivalents | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $53.0K | $53.0K | $53.0K | $53.0K | |||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $0.00 | $33.0K | $31.0K | $30.0K | $29.0K | $27.0K | $28.0K | |||||||||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $0.00 | $0.00 | $66.0K | $98.0K | $130.0K | $192.0K | $223.0K | $253.0K | $313.0K | $342.0K | $371.0K | $428.0K | $456.0K | $484.0K | $538.0K | $565.0K | $592.0K | ||||||||||||||||||||||||||||||||||
| Operating Lease Liability Current | $0.00 | $0.00 | $0.00 | $70.0K | $104.0K | $138.0K | $132.0K | $130.0K | $127.0K | $112.0K | $120.0K | $118.0K | $113.0K | $111.0K | $109.0K | $104.0K | $102.0K | $92.0K | ||||||||||||||||||||||||||||||||||
| Non Cash Equity Adjustments From Parent Company | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash | $10.7M | $10.8M | $13.3M | $5.4M | $4.7M | $6.5M | $8.4M | $11.3M | $3.2M | $5.3M | $2.6M | $3.6M | $5.4M | $7.7M | $10.2M | $2.4M | $3.8M | $4.2M | $4.0M | $6.0M | $6.6M | $5.1M | $11.9M | $9.0M | $6.8M | $8.6M | $19.6M | $6.3M | $7.5M | $304.0K | ||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $7.9M | -$2.0M | -$2.7M | -$3.6M | $18.5M | $6.4M | -$2.1M | |||||||||||||||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $0.00 | $0.00 | $70.0K | $104.0K | $138.0K | $202.0K | $234.0K | $265.0K | $325.0K | $354.0K | $383.0K | $438.0K | $465.0K | $500.0K | |||||||||||||||||||||||||||||||||||||
| Preferred Stock Dividends And Other Adjustments | $700.0K | $1.2M | $1.8M | $1.4M | $2.4M | $3.5M | $1.3M | $10.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $481.0K | $147.0K | $303.0K | $414.0K | $480.0K | $136.0K | $300.0K | $282.0K | $314.0K | $756.0K | $1.5M | $1.8M | $2.0M | $968.0K |
| Financing Cash Flow * | $23.6M | $4.0M | $7.4M | -$26.0K | $21.7M | $16.1M | $772.0K | $18.8M | $292.0K | $10.2M | $9.5M | $1.9M | $15.7M | $9.7M |
| Investing Cash Flow * | -$12.0K | $8.0K | -$5.0K | -$121.0K | -$51.0K | -$19.0K | -$72.0K | -$5.0K | -$103.0K | $5.3M | -$5.6M | $2.9M | -$3.1M | $16.0K |
| Operating Cash Flow * | -$8.0M | -$7.1M | -$10.7M | -$12.1M | -$11.9M | -$8.8M | -$8.6M | -$7.5M | -$9.5M | -$7.8M | -$7.3M | -$7.8M | -$6.3M | -$5.1M |
| Increase Decrease In Accrued Liabilities | $143.0K | -$180.0K | -$83.0K | -$1.6M | $1.3M | $415.0K | -$257.0K | -$560.0K | $129.0K | $519.0K | $104.0K | -$793.0K | $1.0M | $223.0K |
| Increase Decrease In Accounts Payable | $183.0K | -$404.0K | -$122.0K | $496.0K | -$445.0K | -$81.0K | $259.0K | $39.0K | -$608.0K | -$246.0K | $878.0K | $122.0K | -$253.0K | $29.0K |
| Depreciation Depletion And Amortization | $3.0K | $2.0K | $56.0K | $71.0K | $75.0K | $72.0K | $67.0K | $81.0K | $70.0K | $53.0K | $77.0K | $87.0K | $99.0K | $147.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $91.0K | -$481.0K | $196.0K | -$8.0K | -$241.0K | $554.0K | $113.0K | $2.0K | $51.0K | -$161.0K | -$131.0K | $139.0K | $89.0K | $26.0K |
| Payments To Acquire Property Plant And Equipment | $12.0K | $1.0K | $5.0K | $121.0K | $51.0K | $19.0K | $72.0K | $5.0K | $203.0K | $4.0K | $57.0K | $95.0K | $78.0K | $15.0K |
| Proceeds From Warrant Exercises | $5.8M | $4.0M | $0.00 | $2.1M | $3.9M | $72.0K | $105.0K | $0.00 | $198.0K | |||||
| Proceeds From Issuance Of Common Stock | $1.3M | $290.0K | $9.3M | $1.9M | $15.7M | |||||||||
| Increase Decrease In Deferred Revenue | -$47.0K | -$71.0K | -$400.0K | -$298.0K | ||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $30.0K | $5.0K | $26.0K | $28.0K | $1.0K | $2.0K | $3.0K | $0.00 | ||||||
| Payments To Acquire Short Term Investments | $2.0M | $8.0M | $5.0M | $9.0M | ||||||||||
| Increase Decrease In Operating Lease Liability | $0.00 | -$35.0K | -$135.0K | -$125.0K | -$116.0K | -$107.0K | ||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 1.0K | 1.0K | 3.0K | 2.0K | 31.0K | 61.0K | 28.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $51.0K | $43.0K | $52.0K | $15.0K | $32.0K | $89.0K | $94.0K | $111.0K | $103.0K | $83.0K | $186.0K | $143.0K | $132.0K | $67.0K | $37.0K | $30.0K | $43.0K | $47.0K | $62.0K | $160.0K | $39.0K | $37.0K | $41.0K | $43.0K | $119.0K | $114.0K | $128.0K | $227.0K | $294.0K | $385.0K | $447.0K | $411.0K | $454.0K | $457.0K | $491.0K | $449.0K | $429.0K | $628.0K | $214.0K |
| Financing Cash Flow * | $9.2M | -$4.0K | -$38.0K | -$25.0K | $21.7M | $8.5M | $43.0K | $932.0K | $64.0K | $15.6M | $1.0M | ||||||||||||||||||||||||||||
| Investing Cash Flow * | -$2.0K | $0.00 | $0.00 | -$104.0K | -$6.0K | -$10.0K | -$1.0K | $0.00 | $98.0K | $2.0M | -$8.0K | ||||||||||||||||||||||||||||
| Operating Cash Flow * | -$1.3M | -$2.0M | -$2.7M | -$3.5M | -$3.3M | -$2.2M | -$2.2M | -$1.9M | -$2.8M | -$2.9M | -$2.0M | -$2.4M | -$1.1M | -$1.2M | |||||||||||||||||||||||||
| Increase Decrease In Accrued Liabilities | $81.0K | -$13.0K | $331.0K | -$543.0K | $108.0K | $188.0K | -$491.0K | $248.0K | -$32.0K | -$166.0K | $95.0K | -$771.0K | -$54.0K | -$6.0K | |||||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $174.0K | -$337.0K | $123.0K | $46.0K | -$113.0K | -$124.0K | $171.0K | $10.0K | -$447.0K | -$882.0K | $174.0K | $114.0K | -$50.0K | $360.0K | |||||||||||||||||||||||||
| Depreciation Depletion And Amortization | $0.00 | $1.0K | $16.0K | $22.0K | $18.0K | $18.0K | $18.0K | $20.0K | $11.0K | $14.0K | $21.0K | $22.0K | $26.0K | $40.0K | |||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$196.0K | -$459.0K | -$314.0K | $538.0K | -$293.0K | -$49.0K | -$86.0K | -$13.0K | -$25.0K | -$46.0K | -$91.0K | -$77.0K | -$110.0K | -$128.0K | |||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $2.0K | $0.00 | $0.00 | $104.0K | $6.0K | $10.0K | $1.0K | $0.00 | $2.0K | $8.0K | |||||||||||||||||||||||||||||
| Proceeds From Warrant Exercises | $2.7M | $0.00 | $0.00 | $0.00 | $0.00 | $2.1M | $0.00 | $3.9M | $1.0K | $17.0K | $43.0K | $0.00 | $16.0K | ||||||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $932.0K | $64.0K | $15.6M | |||||||||||||||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | -$47.0K | -$29.0K | $359.0K | -$19.0K | |||||||||||||||||||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $4.0K | $25.0K | $25.0K | $0.00 | $2.0K | $0.00 | ||||||||||||||||||||||||||||||||
| Payments To Acquire Short Term Investments | |||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Operating Lease Liability | $0.00 | -$35.0K | -$32.0K | -$30.0K | -$28.0K | -$26.0K | |||||||||||||||||||||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 1.0K | 0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$9.08 | -$46.76 | -$10.10 | -$12.43 | -$1.92 | -$19.33 | -$57.46 | -$5.52 | -$16.41 | -$2.10 | -$0.79 | -$2.88 | -$5.62 | -$0.28 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 12.8M | 4.6M | 460.8K | 128.1K | 2.3M | 674.6K | 5.0M | 16.4M | 10.3M | 4.6M | 36.3M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 1.50B | 1.50B |
| Common Stock Shares Issued | 11.6M | 1.7M | 416.4K | 1.1M | 1.1M | 5.8M | 669.4K | 342.6K | 2.4M | 2.4M | 6.5M | 22.0M | 22.0M | 5.3M | 100.4M |
| Common Stock Shares Outstanding | 11.6M | 1.7M | 416.4K | 1.1M | 1.1M | 5.8M | 669.4K | 342.6K | 2.4M | 1.3M | 6.5M | 22.0M | 11.8M | 5.3M | 100.4M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 6.0M | 787.5K | 231.5K | 1.1M | 1.1M | ||||||||||
| Earnings Per Share Basic | $-1.45 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 787.5K | 231.5K | 1.1M | 1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.45 | -$0.41 | -$1.54 | -$3.62 | -$0.47 | -$10.25 | -$13.27 | -$3.15 | -$3.14 | -$2.22 | -$2.34 | -$0.28 | -$0.20 | -$0.32 | -$0.40 | -$0.34 | -$1.33 | -$4.53 | -$4.62 | -$5.71 | -$0.34 | -$0.46 | -$0.90 | -$1.05 | -$1.12 | -$2.65 | -$0.34 | -$0.34 | -$0.34 | -$0.38 | -$0.50 | -$1.32 | -$0.17 | -$0.23 | -$0.32 | -$0.30 | -$0.39 | -$2.76 | -$0.56 | -$4.13 | -$0.04 | -$0.05 | -$0.05 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.5M | 13.5M | 10.7M | 5.8M | 5.0M | 1.8M | 462.0K | 440.5K | 371.3K | 4.4M | 4.1M | 2.5M | 2.4M | 2.2M | 2.1M | 6.6M | 6.5M | 6.5M | 6.5M | 4.4M | 2.4M | 17.5M | 14.0M | 12.6M | 11.6M | 11.2M | 6.5M | 5.2M | 4.4M | 47.97B | 42.0M | 38.6M | |||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | ||||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | ||||||||
| Common Stock Shares Issued | 5.8M | 4.8M | 4.8M | 958.2K | 510.2K | 4.6M | 2.3M | 2.0M | 1.2M | 13.7M | 13.7M | 13.7M | 13.5M | 13.5M | 13.5M | 5.8M | 5.8M | 2.9M | 25.7M | 25.1M | 23.4M | 4.4M | 4.4M | 2.7M | 23.7M | 23.2M | 22.0M | 6.6M | 6.5M | 6.5M | 64.9M | 64.9M | 31.2M | 21.1M | 14.9M | 13.4M | 11.7M | 11.4M | 321.6M | 157.5M | 156.5M | 100.4M | |||||||
| Common Stock Shares Outstanding | 5.8M | 4.8M | 4.8M | 958.2K | 510.2K | 4.6M | 2.3M | 2.0M | 1.2M | 13.7M | 13.7M | 13.7M | 13.5M | 13.5M | 13.5M | 5.8M | 5.8M | 2.9M | 25.7M | 25.1M | 23.4M | 4.4M | 4.4M | 2.7M | 23.7M | 23.2M | 22.0M | 6.6M | 6.5M | 6.5M | 64.9M | 64.9M | 31.2M | 21.1M | 14.9M | 13.4M | 11.7M | 11.4M | 321.6M | 100.4M | 100.4M | 100.4M | |||||||
| Preferred Stock Shares Authorized | 10.0M | 100.0M | 100.0M | 100.0M | 100.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.6K | 9.4K | 9.4K | ||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.6K | 9.4K | 9.4K | ||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 5.5M | 4.8M | 4.3M | 990.0K | 510.2K | 4.6M | 271.1K | 192.1K | 1.1M | 1.1M | 1.14B | 1.1M | 13.5M | 13.5M | 10.7M | ||||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.44 | $-0.45 | $-0.41 | $-1.54 | $-3.62 | $-0.47 | $-10.25 | $-13.27 | $-3.15 | $-3.14 | $-2.22 | $-2.34 | $-0.28 | $-0.20 | $-0.32 | ||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 4.8M | 4.3M | 990.0K | 510.2K | 4.6M | 271.1K | 192.1K | 1.1M | 1.1M | 1.14B | 1.1M | 13.5M | 13.5M | 10.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $481.0K | $147.0K | $303.0K | $414.0K | $480.0K | $136.0K | $300.0K | $282.0K | $314.0K | $756.0K | $1.5M | $1.8M | $2.0M | $968.0K | $122.0K | $4.4M | $4.2M | $3.8M | $1.8M |
| Additional Paid In Capital | $175.2M | $151.1M | $146.9M | $139.2M | $138.8M | $116.6M | $100.6M | $99.5M | $80.4M | $73.4M | $66.0M | $48.0M | $41.0M | $11.3M | $3.7M | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $2.1M | $3.9M | $72.0K | $105.0K | $3.2M | $166.0K | $434.0K | $224.0K | |||||||||||
| Stock Issued During Period Value New Issues | $4.0M | $7.5M | $6.9M | $5.0M | -$58.0K | $1.3M | $290.0K | $152.0K | $64.0K | $1.9M | $15.7M | $6.2M | |||||||
| Conversion Of Stock Amount Converted1 | $6.8M | $3.9M | $434.0K | $224.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $113.0K | $51.0K | $43.0K | $52.0K | $15.0K | $32.0K | $89.0K | $94.0K | $111.0K | $103.0K | $83.0K | $186.0K | $143.0K | $132.0K | $67.0K | $37.0K | $30.0K | $43.0K | $47.0K | $62.0K | $160.0K | $39.0K | $37.0K | $41.0K | $628.0K | |||||||||||||||
| Additional Paid In Capital | $162.5M | $160.4M | $160.3M | $149.7M | $147.0M | $147.0M | $144.5M | $144.4M | $139.3M | $139.2M | $139.1M | $139.0M | $138.7M | $138.6M | $138.4M | $116.6M | $116.6M | $109.2M | $99.8M | $99.8M | $99.7M | $85.9M | $86.0M | $81.4M | $80.0M | $80.0M | $79.8M | $66.8M | $66.5M | $66.3M | $65.5M | $65.1M | $52.3M | $47.5M | $44.6M | $42.0M | $40.6M | $40.2M | $39.6M | $11.2M |
| Stock Issued During Period Value Conversion Of Convertible Securities | $40.0K | $2.7M | $0.00 | $0.00 | $2.1M | $3.9M | $1.0K | $17.0K | $43.0K | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $6.5M | $2.6M | $5.0M | $6.9M | $3.5M | $1.5M | -$52.0K | $21.0K | $359.0K | $932.0K | $15.6M | |||||||||||||||||||||||||||||
| Conversion Of Stock Amount Converted1 | $3.5M | $3.7M | $672.0K |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.